Former Süd-Chemie Manager Hans-Joachim Müller to Leave Clariant

Dr. Hans-Joachim Müller, who is a member of the Executive Committee of...
Dr. Hans-Joachim Müller, who is a member of the Executive Committee of Clariant, has decided to leave the company on June 30, 2012.

Former member of the Managing Board of Süd-Chemie, Dr. Hans-Joachim Müller, who is now member of the Executive Committee of Clariant, has decided to leave the company on June 30, 2012, for personal reasons. His current responsibilities will be transferred to the other members of the Executive Committee.

After the acquisition of Süd-Chemie by Clariant, Müller was appointed member of the Executive Committee of the Swiss specialty chemicals manufacturer in July 2011. His responsibilities include Environment Safety & Health Affairs, Innovation Excellence, and the Business Units Catalysis & Energy, Emulsions, Detergents & Intermediates, and Oil & Mining Services.

Until March 31, 2012, he was a member of the Managing Board of Süd-Chemie. In this position, Hans-Joachim Müller was responsible for the entire Süd-Chemie operations since 2011. He initially joined the Managing Board of Süd-Chemie in 2007.

"I want to thank Hans Joachim Müller for his commitment and dedication during his time with our company, in particular for his contributions to the integration of Süd-Chemie during the recent 12 months," said Hariolf Kottmann, CEO. "I wish him all the best and continued success in his future endeavors."

Company

Logo:

Clariant International Ltd

Rothausstr. 61
CH-4132 Muttenz
Switzerland

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.